PAVARANA, Michele
 Distribuzione geografica
Continente #
NA - Nord America 307
EU - Europa 204
AS - Asia 104
SA - Sud America 2
Totale 617
Nazione #
US - Stati Uniti d'America 307
CN - Cina 66
IE - Irlanda 47
IT - Italia 34
GB - Regno Unito 31
SE - Svezia 30
FR - Francia 24
DE - Germania 11
FI - Finlandia 10
SG - Singapore 10
RU - Federazione Russa 7
VN - Vietnam 7
KR - Corea 5
IR - Iran 4
JP - Giappone 4
IL - Israele 3
UA - Ucraina 3
BE - Belgio 2
IN - India 2
PT - Portogallo 2
AL - Albania 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ES - Italia 1
HK - Hong Kong 1
ID - Indonesia 1
KG - Kirghizistan 1
Totale 617
Città #
Chandler 84
Dublin 47
Southend 30
Ashburn 28
Jacksonville 23
Redmond 20
New York 17
Beijing 13
Verona 12
Woodbridge 12
Jinan 10
Lawrence 9
Princeton 9
Wilmington 8
Helsinki 7
Sindelfingen 7
Singapore 7
Seoul 5
Tianjin 5
Ann Arbor 4
Milan 4
Taizhou 4
Tokyo 4
Bologna 3
Shenyang 3
Zhengzhou 3
Brussels 2
Dong Ket 2
Dongguan 2
Guangzhou 2
Nanjing 2
Padova 2
Pieve Emanuele 2
Santa Clara 2
Seattle 2
Tel Aviv 2
Washington 2
Zibo 2
Bishkek 1
Boardman 1
Brno 1
Buffalo 1
Changsha 1
Chaoyang 1
Columbus 1
Hangzhou 1
Hebei 1
Hong Kong 1
Kent 1
Lanzhou 1
Lappeenranta 1
London 1
Los Angeles 1
Mogliano Veneto 1
Nanchang 1
Nashville 1
Ningbo 1
Phoenix 1
Pompei 1
Quito 1
Redwood City 1
Sacramento 1
San Diego 1
San Jose 1
Taiyuan 1
Tirana 1
Tombolo 1
Totale 431
Nome #
Pathological,biological and clinical characteristics and surgical mamagement of ederly women with brest cancer 91
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 82
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 80
Clinical pathways in gastric cancer care 66
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 62
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 53
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 50
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 40
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 38
Predictors of Local Control for Stereotactic Ablative Radiotherapy (SAbR) in Pulmonary Oligometastases from Gastrointestinal Malignancies 30
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 21
Active surveillance for clinical complete responders after chemoradiotherapy for oesophageal squamous cell carcinoma 19
Totale 632
Categoria #
all - tutte 2.507
article - articoli 2.507
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 3 1 0 2 5 3 5 3 0 7 2 9
2020/202181 4 6 3 12 4 10 0 9 4 1 21 7
2021/202281 4 21 0 2 4 4 0 2 1 9 11 23
2022/2023239 9 26 22 37 16 73 0 20 25 3 5 3
2023/2024155 3 8 6 24 18 33 7 4 13 14 24 1
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 632